| dc.contributor.author | Duraiswamy, Jai | en_US |
| dc.contributor.author | sherritt, Martina | en_US |
| dc.contributor.author | Thomson, Scott | en_US |
| dc.contributor.author | tellam, Judy | en_US |
| dc.contributor.author | Cooper, Leanne | en_US |
| dc.contributor.author | Connolly, Goeff | en_US |
| dc.contributor.author | BHARADWAJ, MANDVI | en_US |
| dc.contributor.author | Khanna, Rajiv | en_US |
| dc.date.accessioned | 2014-05-21T19:21:21Z | |
| dc.date.available | 2014-05-21T19:21:21Z | |
| dc.date.issued | 2003 | en_US |
| dc.identifier | 00064971 | en_US |
| dc.identifier.citation | Duraiswamy, J. sherritt, M. Thomson, S. tellam, J. Cooper, L. Connolly, G. BHARADWAJ, M. & Khanna, R. (2003). Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. Blood, 101(8), 3150-3156. | en_US |
| dc.identifier.uri | http://hdl.handle.net/11343/26156 | |
| dc.description | C1 - Journal Articles Refereed | |
| dc.format | application/pdf | en_US |
| dc.subject | Cellular Immunology; Immune System and Allergy | en_US |
| dc.title | Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma. | en_US |
| dc.type | Journal Article | en_US |
| melbourne.peerreview | Peer Reviewed | en_US |
| melbourne.affiliation | The University of Melbourne | en_US |
| melbourne.affiliation.department | Microbiology And Immunology | en_US |
| melbourne.source.title | Blood | en_US |
| melbourne.source.volume | 101 | en_US |
| melbourne.source.issue | 8 | en_US |
| melbourne.source.pages | 3150-3156 | en_US |
| melbourne.publicationid | 62365 | |
| melbourne.elementsid | NA | |
| melbourne.contributor.author | Bharadwaj, Mandvi | |
| melbourne.accessrights | This item is currently not available from this repository | |
